Kisqali Femara Co-Pack and Siltuximab Intravenous
Determining the interaction of Kisqali Femara Co-Pack and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack-Silvadene
- Kisqali Femara Co-Pack-Silvadene Topical
- Kisqali Femara Co-Pack-SilvaSorb
- Kisqali Femara Co-Pack-Silver
- Kisqali Femara Co-Pack-Silver Nitrate
- Kisqali Femara Co-Pack-Silver Nitrate Applicators
- Siltuximab Intravenous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Siltuximab Intravenous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Siltuximab Intravenous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Siltuximab Intravenous-Kitabis Pak
- Siltuximab Intravenous-Kitabis Pak inhalation
- Siltuximab Intravenous-Klofensaid II